Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Comparison of Topical and Intravenous Tranexamic Acid to Reduce the Number of Blood Transfusions in TKA

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (greater than 18 years old)~* Patients scheduled for primary unilateral knee arthroplasty~* Patients for La Paz- Cantoblanco Hospital, Madrid, Spain~Exclusion Criteria:~* Patients that refuse to sign the Inform Consent~* Allergy to tranexamic acid~* Major comorbidities: Severe ischemic heart disease(class III and IV of New York Heart Association); sleep apnea syndrome; severe EPOC; renal dysfunction (plasma creatinine\>2mg/dL if mens and \>1.8mg/dL if woman); or hepatic disfunction.~* Coagulopathy (preoperative platelet count \<150,000/mm3, INR\>1.4, prolonged PPT(\>1.4 x normal)~* History of thromboembolic disease: CVA, DVT, PE~* Blood dyscrasias~* Retinopathy (disturbances of color vision)~* Jehovah's witnesses~* Pregnancy~* Breastfeeding~* Been participating or been participated a year ago in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental (Type: EXPERIMENTAL): 1. Topical administration of 3g of Tranexamic Acid in 100mL of normal saline (0.9% sodium chloride) as follow:~   * 50mL by irrigation before wound closure~  * 50mL by intraarticular administration (Drenofast) after wound closure.~2. Intravenous administration of Normal saline (0.9% sodium chloride) as follow:~   * 100mL before tourniquet realised~  * 100mL 3 hours after surgery
- Comparator (Type: ACTIVE_COMPARATOR): 1. Topical administration of Normal saline (0.9% sodium chloride) as follow:~   * 50mL by irrigation before wound closure~  * 50mL by intraarticular administration (Drenofast) after wound closure~2. Intravenous administration of two dosis of Tranexamic Acid as follow:~   * 15mg/kg of Tranexamic Acid in 100mL of normal saline (0.9% sodium chloride), before tourniquet realised~  * 15mg/kg of Tranexamic Acid in 100mL of normal saline (0.9% sodium chloride), 3 hours after surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).